维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="Jnne PA"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Prospective study of gefitinib- in epidermal, growth factor receptor fluorescence in sita hybridiza- tionpositive/phospho-Akt-positive or never smoker patientswith ad- vanced non-small-cell lung cancer : the ONCOBELL trial 显示文摘	Cappuzzo F Ligorio C Jnne PA	2007	J Cli- nOncol2007，25，16：	1
	2	Prospective study of gefitinibin epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial显示文摘	Cappuzzo F Ligorio C Jnne PA	2007	J Clin Oncol2007，25，16：	1
	3	EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy显示文摘	Paez JG Jnne PA LeeJC	2004	Science2004，304，5676：	1
	4	Discovery of selective irrevers- ible inhibitors for EGFR-T790M显示文摘	Zhou W Ercan D Jnne PA etal	2011	Bioorg Med Chem Lett2011，21，2：	1
	5	EGFR mutations in lung cancer: correlation with clinical esponse to gefitinib therapy显示文摘	Paez JG Jnne PA Lee JC	2004	Science2004，304，5676：	1
	6	Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization- positive/phospho- Akt- positive or never smoker patients with advanced non -small -cell lung cancer: the ONCOBELL trial显示文摘	Cappuzzo F Ligorio C Jnne PA	2007	J Clin Oncol2007，25，16：	1
	7	EGFR mutations in lung cancer:correlation with clinical response to gefitinib therapy显示文摘	Paez JG Jnne PA Lee JC		0，，5676：	1
	8	Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial显示文摘	Cappuzzo F Ligorio C Jnne PA	2007	J Clin Oncol2007，25，16：	1
	9	AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer显示文摘	JNNE PA YANG JC-H KIM DW	2015	N Engl J Med2015，372，18：	1
	10	EGFR,HER2 and K-ras as predictive factors for cetuximab sensitivity in colorectal cancer显示文摘	Finocchiaro G Cappuzzo F Jnne PA	2007	J Clin Oncol2007，25，：	1
	11	Prospective study of gefitinib- in epidermal growth factor receptor fluorescence in situ hybridiza- tionpositive/phospho-Akt-positive or never smoker patientswith ad- vanced non-small-cell lung cancer: the ONCOBELL trial 显示文摘	Cappuzzo F Ligorio C Jnne PA	2007	J Cli- nOncol2007，25，16：	1
	12	Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC 显示文摘	OU SH JNNE PA BARTLETT CH	2014	Ann Oncol2014，25，2：	1
	13	Prospective study of gefltinib in epidermal growth factor receptor fluorescence in situ hybridization - positive/phospho - Akt - positive or never smoker patients with advanced non - small - cell lung cancer: the ONCOBELL trial 显示文摘	Cappuzzo F Ligorio C Jnne PA	2007	J Clin Oncol2007，25，16：	1
	14	EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy显示文摘	Paez JG Jnne PA Lee JC	2004	Science2004，304，5676：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费